College of Engineering, Science and Environment, University of Newcastle, Newcastle, Australia.
ARC Centre of Excellence in Synthetic Biology, Macquarie University, Sydney, Australia.
mBio. 2023 Dec 19;14(6):e0120523. doi: 10.1128/mbio.01205-23. Epub 2023 Oct 20.
Gram-negative bacteria are intrinsically resistant to many antibiotics, due in large part to the permeability barrier formed by their cell envelope. The complex and synergistic interplay of the two Gram-negative membranes and active efflux prevents the accumulation of a diverse range of compounds that are effective against Gram-positive bacteria. A lack of detailed information on how components of the cell envelope contribute to this has been identified as a key barrier to the rational development of new antibiotics with efficacy against Gram-negative species. This review describes the current understanding of the role of the different components of the Gram-negative cell envelope in preventing compound accumulation and the state of efforts to describe properties that allow compounds to overcome this barrier and apply them to the development of new broad-spectrum antibiotics.
革兰氏阴性菌对许多抗生素具有内在抗性,这在很大程度上是由于其细胞包膜形成的通透性屏障。革兰氏阴性菌的两层膜之间复杂而协同的相互作用以及主动外排作用阻止了多种对革兰氏阳性菌有效的化合物的积累。缺乏关于细胞包膜成分如何对此产生影响的详细信息,这已被确定为合理开发针对革兰氏阴性菌的新型有效抗生素的主要障碍。本综述描述了目前对革兰氏阴性菌细胞包膜的不同成分在防止化合物积累方面的作用的理解,以及描述允许化合物克服这一障碍的特性并将其应用于新型广谱抗生素开发的努力状态。